08:57 AM EDT, 06/09/2026 (MT Newswires) -- Healthcare stocks were rising pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.4% higher and the iShares Biotechnology ETF (IBB) advancing by 1.1%.

TG Therapeutics ( TGTX ) shares were up more than 3% after the company said it has started a phase 2 trial evaluating BRIUMVI as a maintenance therapy following induction with efgartigimod in adult patients with myasthenia gravis, a chronic autoimmune neuromuscular disease.